Articles tagged with Tuberculosis
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
Researchers at UCLA and Shanghai Jiao Tong University have developed a new feedback system control technique to pinpoint the best possible drug-dose ratios for treating tuberculosis. This approach has identified promising combination treatments that can kill bacteria much faster than standard regimens, potentially shortening treatment ...
Researchers in South Africa are conducting a medical trial focused on controlling tuberculosis (TB) epidemics. The trial uses a novel approach that combines intensified household tracing and screening for TB and HIV using rapid molecular technologies.
Research reveals that smoking damages macrophages, leading to TB infection and worsening its progression. The impaired cells can't recycle debris, becoming 'clogged up' and less effective at fighting infection.
Researchers found that curcumin successfully removes Mycobacterium tuberculosis from infected cells in culture by inhibiting the activation of nuclear factor-kappa B. The study suggests a potential new treatment for drug-resistant tuberculosis that could be less prone to resistance development.
Researchers identified biological markers in blood samples from latently infected individuals that can predict the risk of developing active TB. These biomarkers may enable targeted therapies to prevent illness in high-risk individuals.
Experts from the European Respiratory Society call for improved TB care for refugees to control and eliminate the disease. They emphasize the need for quality surveillance, monitoring, evaluation, and research among this group of people to prevent a rise in new cases.
Researchers aim to collect and analyze 100,000 TB samples to create a database of MDR-TB genes, enabling faster diagnosis using whole genome sequencing. The project, CRyPTIC, will take around five years to complete and could potentially save lives by providing the right treatment.
A large clinical trial found that treating HIV patients at risk for tuberculosis with TB drugs does not save more lives. Simple TB screening and isoniazid preventive therapy were well-tolerated and resulted in similar survival rates compared to a four-drug TB treatment.
A randomized clinical trial found that using four drugs for TB does not improve survival rates over isoniazid therapy in advanced HIV/AIDS patients. The study validates the World Health Organization guidelines for prescribing isoniazid to vulnerable patients.
A study published in PLOS Pathogens suggests that HIV infection disrupts the immune response to Mtb, making it harder for the body to control active TB. Researchers found that early HIV infection diminishes a specific component of the immune response called IL-10, leading to a weaker defense against Mtb.
Researchers found that adding statins to standard drug treatment reduced the time to clear tuberculosis infection by 35% in infected mice. The study suggests that repurposing statin drugs could accelerate TB treatment and improve public health outcomes.
A new study published in The Lancet suggests that a low-cost, urine test to diagnose tuberculosis among patients with HIV could save thousands of lives per year in sub-Saharan Africa. The test, which provides results in 25 minutes and costs $2.66, showed an absolute reduction of 4% in TB death rate among patients with HIV.
A study found that HIV patients in Africa with a certain genetic variant have a 63-percent lower chance of developing tuberculosis than those without the variant. This discovery may lead to the development of new TB treatments effective for both HIV-positive individuals and the general population.
A collection of papers from global health experts argues that investing in new health tools, delivery innovations, and disease control strategies can avert 10 million deaths annually. The collection focuses on five conditions disproportionately affecting the world's poorest people.
A GW chemistry professor is leading a team of researchers to identify enzyme inhibitors as possible medications for devastating diseases like malaria and tuberculosis. The five-year, $2.6 million grant will focus on designing small molecule inhibitors that can stop the production of key enzymes necessary for pathogen survival.
A new methodology developed at Rice and Rutgers universities helps scientists understand how biochemical networks control biological responses. The approach predicted novel interactions in bacteria that cause tuberculosis, revealing a potential mechanism for the disease's survival.
Researchers at Stanford University School of Medicine have developed a simple blood test that can accurately diagnose active tuberculosis, setting the stage for a significant transformation in disease control. The test works on ordinary blood samples and distinguishes patients with active TB from those with latent TB or other diseases.
Researchers at Trinity College Dublin have made a significant discovery in how our immune system responds to TB, enabling the development of more effective vaccines and personalized therapies. The study highlights the importance of the protein Mal in cell signaling and its impact on responses to Interferon Gamma.
Scientists have uncovered the 3D structure of an enzyme crucial for Mycobacterium tuberculosis survival. This discovery could lead to the development of new compounds targeting the ketol-acid reductoisomerase (KARI) enzyme, which is only present in bacteria and plants.
Researchers at Vanderbilt University Medical Center have discovered a new compound that is more effective against the tuberculosis enzyme and maintains activity against resistant forms. The findings could lead to a more effective treatment for the deadly disease, which killed 1.5 million people in 2014.
TB cases decreased in recent US entrants from Mexico, Philippines, India, Vietnam, and China due to decreases in population and TB case rates. Non-recent entrants also experienced an unexpected decline, highlighting the need for strategies impacting both groups to further reduce TB morbidity.
A new study published in the American Journal of Respiratory and Critical Care Medicine found that the most commonly used TB test failed to accurately diagnose tuberculosis in up to 50% of pregnant women who are HIV+. The researchers developed a new method to identify which women carrying latent TB infection are most likely to develop ...
A study found that up to 66.8% of households experience catastrophic health expenditure for tuberculosis care, with the poorest households bearing the brunt. Expanding universal healthcare and increasing reimbursement rates could lower these costs and have positive economic effects.
Researchers found that fluoroquinolones interact with an enzyme in TB germs, but not as strongly as thought. They discovered a new way to make the drugs more potent by targeting broken DNA within the gyrase complex. This could lead to improved treatments for multidrug-resistant TB and other bacterial infections.
A prospective cohort study found that receiving an average of at least six potentially effective drugs per day was associated with a 36% greater likelihood of responding to treatment. The inclusion of more drugs, particularly pyrazinamide, was also linked to improved sputum culture conversion rates.
Clinical research experts discuss various topics, including the impact of personalized genomic data on healthcare systems, strategies to combat multidrug-resistant tuberculosis, and population approaches to reduce diabetes incidence. They also highlight the need for improved cancer diagnosis and treatment for neurodegenerative diseases.
Researchers discover FDA-approved medications with dual-action against bacterial energy production and specific enzymes, potentially reducing resistance. Such multitarget drugs could treat a range of infections, including tuberculosis and Staphylococcus aureus.
The La Jolla Institute will characterize immune responses to dengue virus and Mycobacterium tuberculosis with the HIPC grant. The research aims to identify effective gene signatures for vaccines against these diseases, which are major global health challenges.
A new, inexpensive, and quick method for detecting tuberculosis has been devised, using a nucleic acid amplification test on disposable electrochemical sensors. The modified test, which involves a colorimetric assay that changes to blue if the infection is present, can be performed with minimal equipment and expertise.
The study reveals high genetic diversity of TB strains in Ethiopia, suggesting that Europeans introduced a new wave of virulent strains. The findings contradict the long-held 'virgin soil hypothesis' and shed light on past epidemics of TB.
A new study from the University of Rochester found that early life exposures to toxic chemicals like PCBs and DDE reduce infants' responses to vaccines. The research, which analyzed blood samples from over 500 mother-infant pairs in eastern Slovakia, shows that even small changes can lead to long-term immune system dysfunction.
A computer model of tuberculosis has shown that daily antibiotic regimens are more effective than once or twice a week in preventing drug-resistant strains. The study suggests that increasing the number of doses and improving drug properties can lead to significant improvements in treatment success rates.
The study identified at least three different structural classes of compounds active against multidrug-resistant and extensively drug-resistant strains of tuberculosis. These new inhibitors target the reductive sulfur assimilation pathway, essential for the bacteria's survival in host defense systems.
A recent study has found that treating a parasitic worm infection can reduce lung damage and susceptibility to tuberculosis in mice. The research suggests that using inexpensive anti-parasitic drugs could be an effective way to prevent TB in areas where both infections are common.
A 2-year-old girl was diagnosed and treated for XDR TB, the first detailed account of a young child in the US. The successful treatment highlights the need for better understanding and creative approaches to pediatric tuberculosis.
Researchers have determined the structure of a key enzyme in Mycobacterium tuberculosis, which could lead to new drugs for the disease. The discovery provides a potential starting point for developing treatments that target this enzyme.
TB researchers propose a biosocial approach combining biomedical interventions with social actions to address root causes of the disease, which include poverty, malnutrition, and overcrowding. The strategy aims to reduce morbidity and mortality while alleviating poverty and promoting sustainable development.
Researchers at Tulane National Primate Research Center are working on a new tuberculosis vaccine by modifying Mycobacterium tuberculosis to lose stress response gene SigmaH. Monkeys vaccinated with the modified strain showed better resistance to infection and protective immune responses in their lungs.
A £3.5 million grant will fund a trial to determine whether a weekly vitamin D supplement can prevent tuberculosis (TB) in 5,400 primary schoolchildren in Cape Town. The trial aims to discover whether the supplement can reduce the risk of acquiring latent TB infection, which may develop into active TB later in life.
Research suggests that universal TB screening of immigrants to Canada is costly and inefficient, with most cases detected from a small number of high-risk countries. The study recommends targeting screening on immigrants from countries with high TB rates, rather than universally.
A study found that the majority of active TB cases in Canada were linked to immigrants from Afghanistan, China, India, Pakistan, Philippines, and Vietnam. This suggests that developed countries can focus on screening for TB in high-risk immigrants rather than screening all arrivals.
HIV-infected patients are excluded from early-phase clinical trials of new anti-tuberculosis drugs, resulting in slower development and potential drug interactions with antiretroviral therapy. Experts urge including HIV patients in relevant trials to accelerate development and address drug resistance.
A Phase 2a trial will assess the safety and immunogenicity of IDRI's TB vaccine candidate in 60 participants in South Africa, who have previously had active TB. The trial aims to reduce TB recurrence after treatment, a major threat to TB control programs.
A cluster randomized controlled trial found that electronic reminders via medication monitors and text messages improved tuberculosis treatment adherence, with non-adherent rates decreasing from 29.9% to 17.0%. The study suggests innovative approaches to improve TB treatment outcomes in remote areas.
A new study published in PLOS Medicine found that electronic reminders can significantly improve tuberculosis treatment adherence in China. Patients who received electronic medication monitors missed only 17% of their doses, compared to 29.9% for those with no reminders and 27.3% for those receiving text message reminders.
Researchers from Queen Mary University of London found declining numbers of Bovine TB infections in Scotland and Wales, while England's approach is unlikely to succeed. More frequent testing led to effective control of the disease, with a significant decline in infections.
Researchers have developed three new rapid tests for diagnosing drug-resistant tuberculosis (TB), which can be completed in as little as a day. The tests were found to be accurate in detecting resistance to most anti-TB drugs, with the molecular techniques showing superior performance.
A project in Togo saw a 10% drop in TB death rates by increasing the treatment success rate to 95%, while mortality dropped from 13% to 3%. The redesigned system improved coverage, quality, and patient participation, highlighting the importance of data analysis and skilled workforce.
Researchers have identified a novel virulence factor that could be ripe for drug development, targeting the electron transport process in TB. The discovery of MenJ, a gene essential for the organism's proliferation, offers hope for rapid treatment of the disease.
A new $1.45-million program will enhance the training of scores of Ghanaian researchers in new research methods, grant writing, ethics, and clinical care for TB and HIV patients.
Researchers found that ethoxzolamide inhibits TB's ability to detect acidic environments, effectively blinding the bacterium and allowing the immune system to attack. This compound could help shorten treatment duration and slow the emergence of drug resistance in TB.
Researchers at Rockefeller University have identified a genetic error that makes children susceptible to two unrelated diseases: aggravating fungal infections and invasive, potentially fatal bacterial disease. The mutation affects the RORC gene, which controls the production of cytokines crucial for fighting off mycobacteria.
A study found that starting anti-HIV treatment within two weeks of TB diagnosis improved survival rates among patients with very low CD4 T-cell counts. However, delaying treatment until after TB is completed may be beneficial for patients with stronger immune systems.
EPFL scientists identified lansoprazole as an excellent candidate against tuberculosis, a global pandemic, by screening thousands of approved drugs. The study found that lansoprazole kills the bacterium after being converted into a sulfur-containing metabolite, targeting a crucial enzyme for energy production.
Researchers have discovered a unique process in TB bacteria that uses an additional protein to read DNA, providing a potential new target for antibiotics. This finding could speed up the drug discovery process by allowing scientists to quickly rule out ineffective treatments.
Researchers at SLU's Center for Vaccine Development are studying gamma/delta T cells, a subset of T cells that recognize and fight TB. The goal is to develop a novel vaccine that could significantly reduce TB infection and disease.
A study found that household contacts of multidrug-resistant tuberculosis (MDRTB) patients were 44% less likely to contract tuberculosis than those of drug-susceptible cases. The researchers suggest this may be due to a lower relative fitness of MDRTB strains.
A new study reveals that Mycobacterium tuberculosis hijack protective hypoxic zones in bone marrow stem cells to hide and survive. The research found that these stem cells exhibit strong binding to pimonidazole, indicating hypoxia localization, and express a key gene involved in regulating oxygen levels.
Scientists from HIPS and HZI discover cyclohexylgriselimycin, a variant of griselimycin, effective against Mycobacterium tuberculosis with low risk of resistance development. The new agent targets DNA clamp, preventing bacterial proliferation and offering potential therapeutic approach to drug-resistant tuberculosis.
Researchers at UT Southwestern Medical Center identified an enzyme involved in protecting the body from pathogens that senses Mycobacterium tuberculosis. The study found that modulating cGAS activity could be a novel approach to therapy, and cGAMP may be used as a biomarker for active disease.